Artivion Inc
NYSE:AORT
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
12.88
28.46
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AORT stock under the Base Case scenario is 24.25 USD. Compared to the current market price of 26.33 USD, Artivion Inc is Overvalued by 8%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Artivion Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AORT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Artivion Inc
Balance Sheet Decomposition
Artivion Inc
Current Assets | 285m |
Cash & Short-Term Investments | 55m |
Receivables | 79m |
Other Current Assets | 151m |
Non-Current Assets | 504.6m |
PP&E | 79.1m |
Intangibles | 408.4m |
Other Non-Current Assets | 17.1m |
Current Liabilities | 50.6m |
Accounts Payable | 11.7m |
Accrued Liabilities | 35.2m |
Other Current Liabilities | 3.6m |
Non-Current Liabilities | 443.9m |
Long-Term Debt | 316.5m |
Other Non-Current Liabilities | 127.4m |
Earnings Waterfall
Artivion Inc
Revenue
|
377m
USD
|
Cost of Revenue
|
-133.3m
USD
|
Gross Profit
|
243.6m
USD
|
Operating Expenses
|
-216.4m
USD
|
Operating Income
|
27.2m
USD
|
Other Expenses
|
-35.6m
USD
|
Net Income
|
-8.3m
USD
|
Free Cash Flow Analysis
Artivion Inc
USD | |
Free Cash Flow | USD |
Artivion experienced a robust second quarter in 2024 with revenues reaching $98 million, representing a 10% increase year-over-year, and a 35% rise in adjusted EBITDA. Leading the growth were On-X valves with a 15% increase, and Stent Grafts at 13%. The company amended its agreements with Endospan, improving acquisition terms and adding funding. Looking ahead, Artivion anticipates annual revenue growth between 10% and 12%, raising its guidance to $388-$396 million. Adjusted EBITDA is expected to grow by 28%-34%, hitting $69-$72 million. Key markets in Latin America and Asia Pacific saw significant expansions, with revenue increases of 25% and 15%, respectively.
What is Earnings Call?
AORT Profitability Score
Profitability Due Diligence
Artivion Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Artivion Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
AORT Solvency Score
Solvency Due Diligence
Artivion Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Artivion Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AORT Price Targets Summary
Artivion Inc
According to Wall Street analysts, the average 1-year price target for AORT is 30.93 USD with a low forecast of 29.9 USD and a high forecast of 33.6 USD.
Dividends
Current shareholder yield for AORT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
AORT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Artivion, Inc. focuses on developing solutions that address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,300 full-time employees. The firm is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The firm's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. The company offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The firm's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.
Contact
IPO
Employees
Officers
The intrinsic value of one AORT stock under the Base Case scenario is 24.25 USD.
Compared to the current market price of 26.33 USD, Artivion Inc is Overvalued by 8%.